• $8.1M
    Market Cap
  • -98.11%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
6,202
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
6,318
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
-116
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
789,829
+526.38%
126,094
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-923,914
+540.02%
-144,356
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
N/A
N/A
4.8M
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
19.4M
+526.52%
3.1M
+130.47%
1.3M
+37.26%
976,345
N/A
Operating Profit
-19.4M
+1,378.49%
-1.3M
-129.32%
4.5M
+33.65%
3.3M
N/A
Interest Income
N/A
N/A
548,676
-90.56%
5.8M
+34.67%
4.3M
N/A
Interest Expense
N/A
N/A
-891,624
+9,844.50%
-8,966
N/A
N/A
N/A
Interest Income and Expense and Net
0
+100.00%
-342,948
-105.91%
5.8M
+34.46%
4.3M
N/A
Total Nonoperating Income and Expense
-5.1M
-45.71%
-9.4M
-262.79%
5.8M
+34.46%
4.3M
N/A
Income before Taxes
-24.5M
+1,770.40%
-1.3M
-129.32%
4.5M
+33.65%
3.3M
N/A
Income Taxes
N/A
N/A
-1,013
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
N/A
N/A
4.5M
+33.65%
3.3M
N/A
Net Income from Continuing Operations Applicable to Common
-24.5M
+1,770.40%
-1.3M
-129.32%
4.5M
+33.65%
3.3M
N/A
Basic EPS and Net Income
N/A
N/A
N/A
N/A
0.46
+109.09%
0.22
N/A
Diluted EPS and Net Income
-16.38
N/A
N/A
N/A
0.46
+109.09%
0.22
N/A
Basic Weighted Average Shares
1.5M
N/A
N/A
N/A
19.2M
-39.47%
31.7M
N/A
Diluted Weighted Average Shares
1.5M
N/A
N/A
N/A
19.2M
-39.47%
31.7M
N/A
Balance Sheet
Cash and Cash Equivalents
1.0M
N/A
0
N/A
0
-100.00%
497,259
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
1.0M
N/A
0
N/A
0
-100.00%
497,259
N/A
Total Current Assets
1.3M
+2,762.37%
45,842
-43.56%
81,223
-92.60%
1.1M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
10.8M
-64.80%
30.7M
-90.09%
309.8M
N/A
Total Assets
1.3M
-80.46%
6.7M
-66.40%
20.0M
-93.34%
300.2M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
122,689
N/A
Total Short-Term Debt
1.8M
+41.27%
1.3M
+10,129.59%
12,384
-94.81%
238,596
N/A
Total Current Liabilities
7.6M
-51.38%
15.6M
+3,771.80%
403,328
+32.97%
303,323
N/A
Total Long-Term Debt
2.6M
+173.81%
965,722
N/A
0
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
102.8M
+850.55%
10.8M
0.00%
10.8M
N/A
Total Liabilities
7.7M
-50.77%
15.6M
+3,771.80%
403,328
-96.37%
11.1M
N/A
Retained Earnings
-27.3M
+11.83%
-24.4M
+115.93%
-11.3M
+13.57%
-9.9M
N/A
Total Stockholders Equity
-6.4M
-195.62%
6.7M
+2,170.29%
-322,105
-96.76%
-9.9M
N/A
Total Shares Outstanding
3.5M
-50.84%
7.2M
-50.00%
14.4M
+100.00%
7.2M
N/A
Cash Flow
Cash from Operating Activities
-4.9M
+139.62%
-2.1M
+214.60%
-653,107
-53.64%
-1.4M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
284.9M
+196.68%
-294.7M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
5.9M
+150.52%
-11.7M
-95.88%
-284.8M
-196.01%
296.6M
N/A
Financials Ratio
Gross Margin
-1.87%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-312,016.95%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
N/A
N/A
N/A
N/A
2.79%
N/A
N/A
N/A
Return on Equity
N/A
N/A
N/A
N/A
-87.02%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.17
+5,858.62%
0.003
-98.56%
0.20
N/A
N/A
N/A
Cash Ratio
0.13
N/A
0.00
N/A
0.00
N/A
N/A
N/A
Debt-to-Equity Ratio
-0.70
-307.71%
0.33
+971.88%
-0.04
N/A
N/A
N/A
Debt-to-Assets Ratio
3.38
+916.27%
0.33
+55,316.67%
0.0006
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow